What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/21074 |
Resumo: | Objective: To review the current literature and provide the latest information on anti-resorptive agent-induced osteonecrosis of the jaw (ARONJ), including our basic and clinical research findings, as well as discuss the risks of developing osteonecrosis in patients undergoing dental implant surgery in use of anti-resorptive drugs (ARDs). Methods: A literature review was performed using articles published in indexed journals based on Pubmed, Web of Science, Embase and Scopus databases. Results: Our results show that the placement of dental implants in patients treated with ARDs should be carefully evaluated, these patients are not free from complications and, therefore, the risk assessment should be done individually, as one of the most serious complications, although rare, is the ARONJ. Conclusion: Thus, all patients treated with this type of drug should be informed about the risk of implant loss or the possibility of osteonecrosis, being necessary to inform about the increased risk also patients who already have osteointegrated implants and will start therapy with bisphosphonates (BPT). And, in addition, establishing a relationship and collaboration between doctor, dentist and patient is essential for the good prognosis of these cases. |
id |
UNIFEI_9f20b24d29f56d070b74c85deae27a40 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/21074 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review¿Cuál es el impacto de la farmacoterapia con agentes antirresortivos en el éxito de los implantes dentales? una revisión de la literaturaQual é o impacto da terapia medicamentosa com agentes antirreabsortivos no sucesso dos implantes dentários? uma revisão de literaturaOsteonecrosisAntiresorptive drugsBisphosphonatesDental implantSuccess rate.OsteonecrosisFármacos antirresortivosBisfosfonatosImplante dentalTasa de éxito.OsteonecroseDrogas antirreabsortivasBifosfonatosImplante dentárioTaxa de sucesso.Objective: To review the current literature and provide the latest information on anti-resorptive agent-induced osteonecrosis of the jaw (ARONJ), including our basic and clinical research findings, as well as discuss the risks of developing osteonecrosis in patients undergoing dental implant surgery in use of anti-resorptive drugs (ARDs). Methods: A literature review was performed using articles published in indexed journals based on Pubmed, Web of Science, Embase and Scopus databases. Results: Our results show that the placement of dental implants in patients treated with ARDs should be carefully evaluated, these patients are not free from complications and, therefore, the risk assessment should be done individually, as one of the most serious complications, although rare, is the ARONJ. Conclusion: Thus, all patients treated with this type of drug should be informed about the risk of implant loss or the possibility of osteonecrosis, being necessary to inform about the increased risk also patients who already have osteointegrated implants and will start therapy with bisphosphonates (BPT). And, in addition, establishing a relationship and collaboration between doctor, dentist and patient is essential for the good prognosis of these cases.Objetivo: Revisar la literatura actual y proporcionar la información más reciente sobre la osteonecrosis de la mandíbula inducida por agentes antirresortivos (ARONJ), incluidos los hallazgos de nuestra investigación básica y clínica, así como discutir los riesgos de desarrollar osteonecrosis en pacientes sometidos a cirugía de implantes dentales. en uso de fármacos antirresortivos (ERA). Métodos: Se realizó una revisión de la literatura utilizando artículos publicados en revistas indexadas basadas en las bases de datos Pubmed, Web of Science, Embase y Scopus. Resultados: Nuestros resultados muestran que la colocación de implantes dentales en pacientes tratados con ERA debe ser evaluada cuidadosamente, estos pacientes no están libres de complicaciones y, por lo tanto, la evaluación del riesgo debe realizarse de manera individual, como una de las complicaciones más graves, aunque poco frecuente. , es el ARONJ. Conclusión: Así, todos los pacientes tratados con este tipo de fármacos deben ser informados sobre el riesgo de pérdida del implante o la posibilidad de osteonecrosis, y es necesario informar sobre el aumento del riesgo también a los pacientes que ya tienen implantes osteointegrados e iniciarán terapia con bifosfonatos. (BPT). Y, además, establecer una relación y colaboración entre médico, odontólogo y paciente es fundamental para el buen pronóstico de estos casos.Objetivo: Revisar a literatura atual e fornecer as informações mais recentes sobre osteonecrose dos maxilares induzida por agente antirreabsortivo (ARONJ), incluindo nossos achados de pesquisa básica e clínica, bem como discutir os riscos do desenvolvimento de osteonecrose em pacientes submetidos à cirurgia de implante dentário em uso de drogas antirreabsortivas (ARDs). Métodos: Foi realizada uma revisão de literatura utilizando artigos publicados nos periódicos indexados com base em banco de dados Pubmed, Web of Science, Embase e Scopus. Resultados: Nossos resultados mostram que a colocação de implantes dentários em pacientes tratados com ARDs deve ser avaliada com cautela, esses pacientes não são isentos de complicações e, portanto, a avaliação do risco deve ser feita de forma individualizada, pois uma das complicações mais graves, embora raras, é a ARONJ. Conclusão: Desse modo, todos os pacientes tratados com este tipo de medicamento devem ser informados sobre o risco de perda do implante ou da possibilidade de osteonecrose, sendo necessário informar do risco aumentado também os pacientes que já têm implantes osteointegrados e vão iniciar a terapia com bisfosfonatos (BPT). E, além disso, estabelecer uma relação e colaboração entre médico, dentista e paciente é essencial para o bom prognóstico desses casos.Research, Society and Development2021-10-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2107410.33448/rsd-v10i13.21074Research, Society and Development; Vol. 10 No. 13; e211101321074Research, Society and Development; Vol. 10 Núm. 13; e211101321074Research, Society and Development; v. 10 n. 13; e2111013210742525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/21074/18830Copyright (c) 2021 Gabriela Sumie Yaguinuma Gonçalves; Leandro Marcel Soares Alves; Milena Steluti Marqueshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGonçalves, Gabriela Sumie YaguinumaAlves, Leandro Marcel Soares Marques, Milena Steluti2021-11-21T18:26:28Zoai:ojs.pkp.sfu.ca:article/21074Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:40:33.807106Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review ¿Cuál es el impacto de la farmacoterapia con agentes antirresortivos en el éxito de los implantes dentales? una revisión de la literatura Qual é o impacto da terapia medicamentosa com agentes antirreabsortivos no sucesso dos implantes dentários? uma revisão de literatura |
title |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review |
spellingShingle |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review Gonçalves, Gabriela Sumie Yaguinuma Osteonecrosis Antiresorptive drugs Bisphosphonates Dental implant Success rate. Osteonecrosis Fármacos antirresortivos Bisfosfonatos Implante dental Tasa de éxito. Osteonecrose Drogas antirreabsortivas Bifosfonatos Implante dentário Taxa de sucesso. |
title_short |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review |
title_full |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review |
title_fullStr |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review |
title_full_unstemmed |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review |
title_sort |
What is the impact of drug therapy with antiresorptive agents on the success of dental implants? a literature review |
author |
Gonçalves, Gabriela Sumie Yaguinuma |
author_facet |
Gonçalves, Gabriela Sumie Yaguinuma Alves, Leandro Marcel Soares Marques, Milena Steluti |
author_role |
author |
author2 |
Alves, Leandro Marcel Soares Marques, Milena Steluti |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Gonçalves, Gabriela Sumie Yaguinuma Alves, Leandro Marcel Soares Marques, Milena Steluti |
dc.subject.por.fl_str_mv |
Osteonecrosis Antiresorptive drugs Bisphosphonates Dental implant Success rate. Osteonecrosis Fármacos antirresortivos Bisfosfonatos Implante dental Tasa de éxito. Osteonecrose Drogas antirreabsortivas Bifosfonatos Implante dentário Taxa de sucesso. |
topic |
Osteonecrosis Antiresorptive drugs Bisphosphonates Dental implant Success rate. Osteonecrosis Fármacos antirresortivos Bisfosfonatos Implante dental Tasa de éxito. Osteonecrose Drogas antirreabsortivas Bifosfonatos Implante dentário Taxa de sucesso. |
description |
Objective: To review the current literature and provide the latest information on anti-resorptive agent-induced osteonecrosis of the jaw (ARONJ), including our basic and clinical research findings, as well as discuss the risks of developing osteonecrosis in patients undergoing dental implant surgery in use of anti-resorptive drugs (ARDs). Methods: A literature review was performed using articles published in indexed journals based on Pubmed, Web of Science, Embase and Scopus databases. Results: Our results show that the placement of dental implants in patients treated with ARDs should be carefully evaluated, these patients are not free from complications and, therefore, the risk assessment should be done individually, as one of the most serious complications, although rare, is the ARONJ. Conclusion: Thus, all patients treated with this type of drug should be informed about the risk of implant loss or the possibility of osteonecrosis, being necessary to inform about the increased risk also patients who already have osteointegrated implants and will start therapy with bisphosphonates (BPT). And, in addition, establishing a relationship and collaboration between doctor, dentist and patient is essential for the good prognosis of these cases. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-10-10 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/21074 10.33448/rsd-v10i13.21074 |
url |
https://rsdjournal.org/index.php/rsd/article/view/21074 |
identifier_str_mv |
10.33448/rsd-v10i13.21074 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/21074/18830 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 13; e211101321074 Research, Society and Development; Vol. 10 Núm. 13; e211101321074 Research, Society and Development; v. 10 n. 13; e211101321074 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052808933933056 |